[ Back to EurekAlert! ]

Contact: Greg Lester
glester@wistar.org
215-898-3943
The Wistar Institute

Trial Shows Interferon Lowers HIV‑1 Loads, Sustains CD4 Count in Patients

Loading video...

Caption: Luis Montaner, D.V.M., D.Phil., discusses how the immune system can engage in fighting HIV infection if given the right boost. In a recent study, HIV-infected volunteers suspended their daily antiretroviral therapy to receive weekly doses of interferon‑alpha, an antiviral chemical our bodies produce naturally. The study provides the first clinical evidence for a means of reducing the persistent amount of HIV in patients and the ability to control HIV without continued antiretroviral therapy. Montaner presents his results March 7 at the 2012 Conference on Retroviruses and Opportunistic Infections.

Credit: The Wistar Institute

Usage Restrictions: None

Related news release: Interferon decreases HIV-1 levels, controls virus after stopping antiretroviral therapy


[ Back to EurekAlert! ]